Switch theme
Sign up to access all valuation multiples
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. It has a capacity of more than a thousand hospital beds in three hospital units strategically located in the metropolitan region of the city of Belo Horizonte.
1980
3.7K+
LTM Revenue $402M
LTM EBITDA $38.3M
$574M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Hospital Mater Dei has a last 12-month revenue (LTM) of $402M and a last 12-month EBITDA of $38.3M.
In the most recent fiscal year, Hospital Mater Dei achieved revenue of $410M and an EBITDA of -$28.6M.
Hospital Mater Dei expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Hospital Mater Dei valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $402M | XXX | $410M | XXX | XXX | XXX |
| Gross Profit | $117M | XXX | $123M | XXX | XXX | XXX |
| Gross Margin | 29% | XXX | 30% | XXX | XXX | XXX |
| EBITDA | $38.3M | XXX | -$28.6M | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | -7% | XXX | XXX | XXX |
| EBIT | $19.2M | XXX | $63.1M | XXX | XXX | XXX |
| EBIT Margin | 5% | XXX | 15% | XXX | XXX | XXX |
| Net Profit | -$8.3M | XXX | -$62.3M | XXX | XXX | XXX |
| Net Margin | -2% | XXX | -15% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $147M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 18, 2025, Hospital Mater Dei's stock price is BRL 5 (or $1).
Hospital Mater Dei has current market cap of BRL 1.6B (or $293M), and EV of BRL 3.1B (or $574M).
See Hospital Mater Dei trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $574M | $293M | XXX | XXX | XXX | XXX | $0.07 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 18, 2025, Hospital Mater Dei has market cap of $293M and EV of $574M.
Hospital Mater Dei's trades at 1.4x EV/Revenue multiple, and -20.0x EV/EBITDA.
Equity research analysts estimate Hospital Mater Dei's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Hospital Mater Dei has a P/E ratio of -35.2x.
See valuation multiples for Hospital Mater Dei and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $293M | XXX | $293M | XXX | XXX | XXX |
| EV (current) | $574M | XXX | $574M | XXX | XXX | XXX |
| EV/Revenue | 1.4x | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | 15.0x | XXX | -20.0x | XXX | XXX | XXX |
| EV/EBIT | 30.0x | XXX | 9.1x | XXX | XXX | XXX |
| EV/Gross Profit | 4.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | -35.2x | XXX | -4.7x | XXX | XXX | XXX |
| EV/FCF | 8.2x | XXX | -45.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialHospital Mater Dei's last 12 month revenue growth is 6%
Hospital Mater Dei's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $16K for the same period.
Hospital Mater Dei's rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Hospital Mater Dei's rule of X is 24% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Hospital Mater Dei and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | -7% | XXX | XXX | XXX |
| EBITDA Growth | 143% | XXX | -9% | XXX | XXX | XXX |
| Rule of 40 | 31% | XXX | -1% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 24% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $16K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 15% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Hospital Mater Dei acquired XXX companies to date.
Last acquisition by Hospital Mater Dei was XXXXXXXX, XXXXX XXXXX XXXXXX . Hospital Mater Dei acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Hospital Mater Dei founded? | Hospital Mater Dei was founded in 1980. |
| Where is Hospital Mater Dei headquartered? | Hospital Mater Dei is headquartered in Brazil. |
| How many employees does Hospital Mater Dei have? | As of today, Hospital Mater Dei has 3.7K+ employees. |
| Who is the CEO of Hospital Mater Dei? | Hospital Mater Dei's CEO is Mr. Henrique Moraes Salvador Silva. |
| Is Hospital Mater Dei publicy listed? | Yes, Hospital Mater Dei is a public company listed on BVMF. |
| What is the stock symbol of Hospital Mater Dei? | Hospital Mater Dei trades under MATD3 ticker. |
| When did Hospital Mater Dei go public? | Hospital Mater Dei went public in 2021. |
| Who are competitors of Hospital Mater Dei? | Similar companies to Hospital Mater Dei include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Hospital Mater Dei? | Hospital Mater Dei's current market cap is $293M |
| What is the current revenue of Hospital Mater Dei? | Hospital Mater Dei's last 12 months revenue is $402M. |
| What is the current revenue growth of Hospital Mater Dei? | Hospital Mater Dei revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Hospital Mater Dei? | Current revenue multiple of Hospital Mater Dei is 1.4x. |
| Is Hospital Mater Dei profitable? | Yes, Hospital Mater Dei is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Hospital Mater Dei? | Hospital Mater Dei's last 12 months EBITDA is $38.3M. |
| What is Hospital Mater Dei's EBITDA margin? | Hospital Mater Dei's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of Hospital Mater Dei? | Current EBITDA multiple of Hospital Mater Dei is 15.0x. |
| What is the current FCF of Hospital Mater Dei? | Hospital Mater Dei's last 12 months FCF is $69.7M. |
| What is Hospital Mater Dei's FCF margin? | Hospital Mater Dei's last 12 months FCF margin is 17%. |
| What is the current EV/FCF multiple of Hospital Mater Dei? | Current FCF multiple of Hospital Mater Dei is 8.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
